 MARSEILLE, France, Feb. 17, 2021 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH ISIN: FR0010331421; Nasdaq: IPHA Innate or the Company announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor conference: 